Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.

RETRACTED: Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects

1992 • 529 citations

Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.

1984 • 471 citations

Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection

1985 • 410 citations

Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors.

1988 • 257 citations

Long-term survival in ovarian cancer

1991 • 210 citations

Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.

1991 • 194 citations

Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.

1983 • 194 citations

Gamma-interferon inhibits collagen synthesis in vivo in the mouse.

1987 • 181 citations

Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.

1985 • 181 citations

Experimental and clinical results with intraperitoneal cisplatin.

1985 • 150 citations

Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.

1986 • 139 citations

Cyclophosphamide Plus Cisplatin Versus Cyclophosphomide, Doxorubicin, and Cisplatin Chemotherapy of Ovarian-carcinoma - a Metaanalysis

1991 • 132 citations

Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. I.

1982 • 112 citations

Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection.

1987 • 94 citations

Intraperitoneal chemotherapy: technical experience at five institutions.

1985 • 92 citations

Intraperitoneal Administration of Interleukin-2 in Patients With Cancer

1986 • 91 citations

Recombinant gamma, alpha, and beta interferon regulation of human lung fibroblast proliferation.

1987 • 90 citations

Ameliorating effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice

1986 • 88 citations

Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cells.

1986 • 87 citations

Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration

1988 • 84 citations

Anti‐tumor and immunomodulatory activity of intraperitoneal IFN‐γ in ovarian carcinoma patients with minimal residual tumor after chemotherapy

1992 • 79 citations

Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.

1990 • 73 citations

Biologicals and biological response modifiers: fourth modality of cancer treatment.

1984 • 73 citations

Interferon-α and interferon-γ reduce excessive collagen synthesis and procollagen mRNA levels of scleroderma fibroblasts in culture

1988 • 65 citations

Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.

1988 • 62 citations

Therapeutic potential of tumor necrosis factor-alpha and gamma-interferon in experimental human ovarian cancer.

1987 • 61 citations

Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study.

1990 • 61 citations

Intraperitoneal human recombinant interferon alpha-2b in minimal residual ovarian cancer

1990 • 61 citations

Direct and indirect effects of human recombinant gamma-interferon on tumor cells in a clonogenic assay.

1986 • 60 citations

A phase I trial of intraperitoneal recombinant gamma-interferon in advanced ovarian carcinoma.

1988 • 58 citations

Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cells.

1990 • 56 citations

Gamma-interferon: physiology and speculation on its role in medicine.

1987 • 56 citations

Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin‐2 activated killer cells and by activated monocytes

1987 • 54 citations

Intraperitoneal chemotherapy in the management of ovarian cancer

1993 • 54 citations

Intraperitoneal administration of interferon β in ovarian cancer patients

1985 • 54 citations

Long-Term Follow-Up and Prognostic Factors in Ovarian Carcinoma: The Radiumhemmet series 1958 to 1973

1982 • 53 citations

Interferon-γ is required in activation of macrophages for tumor cytotoxicity

1983 • 53 citations

Evaluation of the role of second‐look surgery in ovarian cancer

1989 • 51 citations

A phase I–II trial of intraperitoneal cisplatin and α-lnterferon in patients with persistent epithelial ovarian cancer

1990 • 47 citations

Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinoma.

1991 • 45 citations

Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvum

1985 • 42 citations

Effectiveness of routine and spontaneous follow-up visits for breast cancer

1989 • 41 citations

Antitumor activity of gamma-interferon in ascitic and solid tumor models of human ovarian cancer.

1991 • 39 citations

A Phase II Study of the Efficacy of Recombinant Interferon Gamma in Relapsing Ovarian Adenocarcinoma

1988 • 36 citations

Eradication of mouse melanoma by combined treatment with recombinant human interleukin 2 and recombinant murine interferon‐gamma

1988 • 36 citations

Survival after second-look laparotomy in advanced ovarian epithelial cancer

1989 • 27 citations

Proliferative and antiproliferative effects of interferon-'Y and tumor necrosis factor-α. on cell lines derived from cervical and ovarian malignancies

1990 • 26 citations

Anti‐tumor effects of interferon in mice injected with interferonsensitive and interferon‐resistant friend leukemia cells. VI. Adjuvant therapy after surgery in the inhibition of liver and spleen metastases

1987 • 19 citations

Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycin.

1986 • 15 citations

Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay

1987 • 12 citations

Ovarian malignancies : diagnostic and therapeutic advances

1987 • 10 citations

Differential macrophage-mediated cytotoxicity to P388 leukemia cells and its drug-resistant cells examined by a new MTT assay

1992 • 8 citations

Characterization of the indirect antitumor effect of gamma-interferon using ascites-associated macrophages in a human tumor clonogenic assay.

1987 • 8 citations

Differential Efficacies of Recombinant Murine Interferon-γ and Recombinant Human Interleukin 2 Against EL4-Bearing Mice

1988 • 6 citations